IRADIMED CORPORATION (IRMD)

Market Cap	681.32M
Revenue (ttm)	71.31M
Net Income (ttm)	18.63M
Shares Out	12.67M
EPS (ttm)	1.46
PE Ratio	36.87
Forward PE	33.86
Dividend	$0.60 (1.12%)
Ex-Dividend Date	Nov 15, 2024

Volume	5,654
Open	53.45
Previous Close	53.84
Day's Range	53.30 - 53.88
52-Week Range	40.18 - 57.95
Beta	0.83
Analysts	Strong Buy
Price Target	60.00 (+11.61%)
Earnings Date	Oct 31, 2024

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump mo...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 16, 2014
• Employees: 148
• Stock Exchange: NASDAQ
• Ticker Symbol: IRMD
• Website: https://www.iradimed.com

Financial Performance

In 2023, IRADIMED CORPORATION's revenue was $65.56 million, an increase of 23.00% compared to the previous year's $53.30 million. Earnings were $17.19 million, an increase of 34.02%.

Analyst Forecast

According to one analyst, the rating for IRMD stock is "Strong Buy" and the 12-month stock price forecast is $60.0.

Price Target

$60.0

(11.61% upside)

Analyst Consensus: Strong Buy